CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea

Seung Hoon Beom, Jisu Oh, Tae-Yong Kim, Kyung-Hun Lee, Yaewon Yang, Koung Jin Suh, Hyeong-Gon Moon, Sae-Won Han, Do-Youn Oh, Wonshik Han, Tae-You Kim, Dong-Young Noh, Seock-Ah Im

Cancer Research and Treatment. 2017;49(2):454-463. Published online 2016 August 23 DOI: https://doi.org/10.4143/crt.2016.259

417 POSTER Maintenance hormone therapy with letrozole after first-line chemotherapy in postmenopausal patients with hormone receptor-positive metastatic breast cancer

European Journal of Cancer Supplements. 2005;3(2):117

Link1 Link2

Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial

J. Huober, P.A. Fasching, M. Barsoum, L. Petruzelka, D. Wallwiener, C. Thomssen, T. Reimer, S. Paepke, H.A. Azim, V. Ragosch, E. Kubista, A.K. Baumgärtner, M.W. Beckmann, C. May, I. Nimmrich, N. Harbeck

The Breast. 2012;21(1):27-33

Link1 Link2

Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting

K. Matter-Walstra, M. Schwenkglenks, K. J. Dedes

Breast Cancer Research and Treatment. 2017;163(3):635-635

Link1

Link2 Link3

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea

Seung Hoon Beom, Jisu Oh, Tae-Yong Kim, Kyung-Hun Lee, Yaewon Yang, Koung Jin Suh, Hyeong-Gon Moon, Sae-Won Han, Do-Youn Oh, Wonshik Han, Tae-You Kim, Dong-Young Noh, Seock-Ah Im

Cancer Research and Treatment. 2017;49(2):454-463

Link1 Link2

Link3

PR86 RETROSPECTIVE STUDY OF EVEROLIMUS WITH FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE METASTATIC BREAST CANCER PRETREATED WITH AROMATASE INHIBITORS(AI'S) AND SELECTIVE ESTROGEN MODIFIERS

Leen Vanacker

The Breast. 2015;24:S51

Link1 Link2

5048 A Q-TWiST analysis of lapatinib plus letrozole compared with letrozole alone as first-line therapy in hormone receptor positive (HR+) metastatic breast cancer (MBC)

B. Sherrill, M. Amonkar, B. Sherif, J. Maltzman, L. O'Rourke, S. Johnston

European Journal of Cancer Supplements. 2009;7(2):275

Link1 Link2

Letrozole in First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women Is Superior to Tamoxifen

Clinical Breast Cancer. 2001;1(4):272-273

Link1 Link2

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

Hikmat Abdel-Razeq

Cancer Management and Research. 2016;Volume 8:127-128

Link1 Link2

William Gradishar

Cancer Management and Research. 2016;Volume 8:85-94

Link1

S4 Letrozole vs. Tamoxifen as adjuvant endocrine therapy for postmenopausal women in receptor-positive breast cancer. BIG 1-98: A prospective randomized double-blind phase III study

The Breast. 2005;14:S3

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.